The higher drug CL in obese patients can also be explained by some physiological changes during obesity, such as increased blood flow, activation of the renin–angiotensin system, and glomerular hyperfiltration (Gouju and Legeay, 2023). The gene discussed is REN; the disease is obesity due to melanocortin 4 receptor deficiency.